Distribution and expression of picalm in alzheimer disease

Journal of Neuropathology and Experimental Neurology

Volumn 69, Issue 10, 2010, Pages 1071-1077

  Baig, Shabnam ^a   Joseph, Sally A ^a   Tayler, Hannah ^a   Abraham, Richard ^b   Owen, Michael J ^b   Williams, Julie ^b   Kehoe, Patrick G ^a   Love, Seth ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Amyloid; Alzheimer disease; Clathrin mediated endocytosis; Endothelial cells; Picalm

Indexed keywords

ADAPTOR PROTEIN; AMYLOID A PROTEIN; CLATHRIN ASSEMBLY PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; PHOSPHATIDYLINOSITOL BINDING CLATHRIN ASSEMBLY PROTEIN; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; BLOOD CLOTTING FACTOR 8; CD31 ANTIGEN; F8 PROTEIN, HUMAN; PICALM PROTEIN, HUMAN;

ALZHEIMER DISEASE; ANTIBODY LABELING; ARTICLE; BRAIN TISSUE; ENDOTHELIUM CELL; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; AGED; BRAIN; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; NONPARAMETRIC TEST; PATHOLOGY; PHYSIOLOGY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANTIGENS, CD31; BRAIN; ENDOTHELIAL CELLS; FACTOR VIII; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MONOMERIC CLATHRIN ASSEMBLY PROTEINS; RNA, MESSENGER; STATISTICS, NONPARAMETRIC;

EID: 77957965527     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3181f52e01     Document Type: Article

References (23)

1. Harold D, Abraham R, Hollingworth P, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 2009;41:1088-93
2. Lambert J-C, Heath S, Even G, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 2009;41:1094-99
3. Dreyling MH, Martinez-Climent JA, Zheng M, et al. The t(10;11)(p13; q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family. Proc Natl Acad Sci U S A 1996;93:4804-9
4. Ford MG, Pearse BM, Higgins MK, et al. Simultaneous binding of PtdIns(4,5)P2 and clathrin by AP180 in the nucleation of clathrin lattices on membranes. Science 2001;291:1051-55
5. Marsh M, McMahon HT. The structural era of endocytosis. Science 1999;285:215-20
6. Nordstedt C, Caporaso GL, Thyberg J, et al. Identification of the Alzheimer b/A4 amyloid precursor protein in clathrin-coated vesicles purified from PC12 cells. J Biol Chem 1993;268:608-12
7. Koo EH, Squazzo SL. Evidence that production and release of amyloid A-protein involves the endocytic pathway. J Biol Chem 1994;269: 17386-89
8. Cirrito JR, Kang J-E, Lee J, et al. Endocytosis is required for synaptic activityYdependent release of amyloid-A in vivo. Neuron 2008;58:42-51
9. Kyriazis GA, Wei Z, Vandermey M, et al. Numb endocytic adapter proteins regulate the transport and processing of the amyloid precursor protein in an isoform-dependent manner: Implications for Alzheimer disease pathogenesis. J Biol Chem 2008;283:25492-502
10. Yao PJ, Zhang P, Mattson MP, et al. Heterogeneity of endocytic proteins: Distribution of clathrin adaptor proteins in neurons and glia. Neuroscience 2003;121:25-37
11. Tebar F, Bohlander SK, Sorkin A. Clathrin assembly lymphoid myeloid leukemia (CALM) protein: Localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic. Mol Biol Cell 1999;10:2687-702
12. Wu F, Yao PJ. Clathrin-mediated endocytosis and Alzheimer's disease: An update. Ageing Res Rev 2009;8:147-49
13. Kim JA, Kim HL. Cleavage of purified neuronal clathrin assembly protein (CALM) by caspase 3 and calpain. Exp Mol Med 2001;33:245-50
14. Chen WJ, Goldstein JL, Brown MS. NPXY, a sequence often found in cytoplasmic tails, is required for coated pitYmediated internalization of the low density lipoprotein receptor. J Biol Chem 1990;265:3116-23
15. Kirchhausen T, Bonifacino JS, Riezman H. Linking cargo to vesicle formation: Receptor tail interactions with coat proteins. Curr Opin Cell Biol 1997;9:488-95
16. Bushlin I, Petralia RS, Wu F, et al. Clathrin assembly protein AP180 and CALM differentially control axogenesis and dendrite outgrowth in embryonic hippocampal neurons. J Neurosci 2008;28:10257-71
17. Rudinskiy N, Grishchuk Y, Vaslin A, et al. Calpain hydrolysis of >- and A2-adaptins decreases clathrin-dependent endocytosis and may promote neurodegeneration. J Biol Chem 2009;284:12447-58
18. Heyman A, Fillenbaum GG, Mirra SS. Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Clinical, neuropsychological, and neu-ropathological components. Aging (Milano) 1990;2:415-24
19. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging 1997;18:S1-2
20. Chalmers K, Wilcock GK, Love S. APOE e4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of Ab protein. Neuropathol Appl Neurobiol 2003;29:231-38
21. Olichney JM, Hansen LA, Galasko D, et al. The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology 1996;47:190-96
22. Miners JS, Baig S, Tayler H, et al. Neprilysin and insulin-degrading enzyme levels are increased in Alzheimer disease in relation to disease severity. J Neuropathol Exp Neurol 2009;68:902-14
23. Palmer JC, Baig S, Kehoe PG, et al. Endothelin-converting enzyme-2 is increased in Alzheimer's disease and up-regulated by AA. Am J Pathol 2009;175:262-70